Medicare Enrolled
Dr. Robert Panvini, MD
Urology Physician · San Jose, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Panvini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Panvini?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Panvini
Dr. Robert Panvini is an urology physician in San Jose, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Panvini performed 4,565 Medicare services across 2,449 unique beneficiaries.
Between the years covered by Open Payments, Dr. Panvini received a total of $10,770 from 54 pharmaceutical and/or device companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Panvini is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in CA
$10,770 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,565
Medicare services
Top 19% in CA for urology physician
2,449
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~240 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
870 | $4 | $13 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
747 | $11 | $51 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
556 | $34 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
466 | $112 | $239 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
405 | $81 | $200 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
204 | $69 | $70 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 123 | $139 | $419 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
82 | $110 | $337 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
69 | $34 | $70 |
| Chlamydia trachomatis nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample. |
69 | $34 | $70 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
69 | $34 | $70 |
| Gonorrhea nucleic acid amplification test A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample. |
69 | $34 | $70 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
69 | $34 | $70 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
69 | $34 | $70 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
69 | $34 | $70 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
69 | $34 | $70 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the Trichomonas vaginalis parasite. This method identifies the presence of the organism responsible for trichomoniasis. |
69 | $34 | $70 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
66 | $83 | $315 |
| Mycoplasma genitalium DNA/RNA test A laboratory test that uses DNA or RNA probes to detect the presence of Mycoplasma genitalium bacteria in a sample. |
65 | $34 | $70 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
52 | $34 | $88 |
| New patient office visit, complex (60-74 min) | 39 | $168 | $451 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
38 | $248 | $512 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
37 | $149 | $546 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
35 | $138 | $357 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $160 | $319 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
27 | $9 | $196 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $129 | $363 |
| Gardnerella vaginalis detection test A laboratory test that uses an amplified probe technique to detect the presence of Gardnerella vaginalis bacteria. |
25 | $34 | $70 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
23 | $332 | $730 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
14 | $368 | $751 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
14 | $30 | $508 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,770
Total received (2018-2024)
Avg $1,539/year across 7 years
Top 19% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
398
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,970 (74.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,789 (16.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,012 (9.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,092
2023
$2,644
2022
$1,375
2021
$1,653
2020
$812
2019
$1,814
2018
$1,380
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$341
Sumitomo Pharma America, Inc.
$311
AstraZeneca Pharmaceuticals LP
$75
Janssen Biotech, Inc.
$69
ABBVIE INC.
$66
IMMUNITYBIO, INC.
$63
PFIZER INC.
$62
COLOPLAST CORP
$57
ACCORD HEALTHCARE, INC.
$48
Top 3 companies account for 66.6% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$2,262
Janssen Biotech, Inc.
$1,568
Bayer Healthcare Pharmaceuticals Inc.
$971
Sumitomo Pharma America, Inc.
$643
Amgen Inc.
$529
Teleflex LLC
$434
Dendreon Pharmaceuticals LLC
$339
Antares Pharma, Inc.
$307
Bayer HealthCare Pharmaceuticals Inc.
$301
180 Medical, Inc.
$275
UROVANT SCIENCES INC
$274
NxThera, Inc.
$263
PFIZER INC.
$259
Endo Pharmaceuticals Inc.
$232
Coloplast Corp
$172
ABBVIE INC.
$150
Duchesnay USA Incorporated
$132
MEDIVATION FIELD SOLUTIONS LLC
$122
AstraZeneca Pharmaceuticals LP
$113
Allergan, Inc.
$104
AbbVie, Inc.
$86
TOLMAR Pharmaceuticals, Inc.
$77
Myriad Genetic Laboratories, Inc.
$72
Progenics Pharmaceuticals, Inc.
$69
IMMUNITYBIO, INC.
$63
Janssen Products, LP
$61
COLOPLAST CORP
$57
Allergan Inc.
$56
Zyla Life Sciences, Inc.
$56
Accord Healthcare, Inc.
$54
Zyla Life Sciences
$53
ACCORD HEALTHCARE, INC.
$48
AbbVie Inc.
$47
Kowa Pharmaceuticals America, Inc.
$41
Tolmar, Inc.
$41
DENTSPLY IH Inc.
$39
Ethicon US, LLC
$38
Photocure Inc
$34
Clarus Therapeutics Inc.
$33
Myovant Sciences Inc.
$27
Foundation Medicine, Inc.
$24
Aytu BioScience, Inc
$24
Assertio Therapeutics, Inc.
$24
NeoTract Inc.
$22
TherapeuticsMD, Inc.
$21
UROGEN PHARMA, INC.
$21
PROCEPT BioRobotics Corporation
$19
EMD Serono, Inc.
$19
Hollister Incorporated
$19
BOSTON SCIENTIFIC CORPORATION
$18
Axonics, Inc.
$17
Avadel Specialty Pharmaceuticals, LLC
$15
Ferring Pharmaceuticals Inc.
$13
Blue Earth Diagnostics Limited
$12
Top 3 companies account for 44.6% of all-time payments
Associated products mentioned in payments ›
ANKTIVA · AVEED · Androgel · AquaBeam Robotic System · Axonics r-SNM System · Axumin · BOTOX · BRAC CDx · BRACANALYSIS CDX · CAMCEVI · CONTINENCE CARE · Cysview · EDEX · ELIGARD · ERLEADA · Erleada · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENTLECATH · GentleCath · IMVEXXY · Infyna Chic · JATENZO · JELMYTO · LUPRON DEPOT · LYNPARZA · LoFric · Luja Coude · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Osphena · Otrexup · PERISTEEN · PROLARIS · PROVENGE · PYLARIFY · Prolia · Rezum · SELF-CATH · SPEEDICATH · SPRIX · Seglentis · SpeediCath · TOVIAZ · UROLIFT · UroLift · UroLift System · VESICARE · VIAGRA · VISTASEAL · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZIPSOR · ZORVOLEX · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
124
Per 100K population
6.5
County median income
$159,674
Nearest hospital
GOOD SAMARITAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Panvini is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Panvini experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Panvini performed 870 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Panvini receive payments from pharmaceutical companies?
Yes. Dr. Panvini received a total of $10,770 from 54 companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Panvini's costs compare to other urology physicians in San Jose?
Dr. Panvini's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Panvini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in San Jose
Browse urology physicians in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology